Tuesday Dec 12, 2023

09 – A New Era of GVHD Prevention Post-HCT, Pt. 2: Progressive Research and the Future of Care

In this two-part episode, Javier Bolaños-Meade, MD, with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Shernan Holtan, MD, with the University of Minnesota discuss advances and innovations in graft-versus-host disease (GVHD) prevention that call for a new standard of care in patients needing allogeneic hematopoietic cell transplantation.

In Part II: Progressive Research and the Future of Care, guests dive deeper into the results of their recently published clinical trial outlining a novel drug combination for GVHD prevention, address the importance of ongoing communication, and take a look at how research is continuing to progress to promote a new standard of care.

To read bios on the panelists and to access additional resources related to this episode, visit Our Site

Comment (0)

No comments yet. Be the first to say something!

Copyright 2021 All rights reserved.

Version: 20241125